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Influenza A(H3N2) has been a major cause of seasonal influenza in humans since
1968, and has evolved by antigenic drift under the constantly changing human herd
immunity. Increasing evidence suggests that the antigenic change occasionally occurred
concomitant with the alterations of the N-glycosylation site profile and hemagglutination
activity of the virion surface protein hemagglutinin (HA). However, the structural basis of
these changes remains largely unclear. To address this issue, we performed molecular
dynamics simulations of the glycosylated HA trimers of the A(H3N2), which has a
novel pattern of Asn-X-Ser/Thr sequons unique in the new A(H3N2) epidemic clade
3C.2a and is characterized by attenuated ability to agglutinate nonhuman erythrocytes.
Comparison of the equilibrated structures of the glycosylated HA trimers with and
without the 3C.2a-specific mutations reveals that the mutations could induce a drastic
reduction in the apical space for the ligand binding via glycan-shield rearrangement. The
results suggest that the 3C.2a strain has evolved an HA structure that is advantageous
for evading pre-existing antibodies, while also increasing the ligand binding specificity.
These findings have structural implications for our understanding of the phenotypic
changes, evolution, and fate of influenza A(H3N2).
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INTRODUCTION
The hemagglutinin (HA) protein of influenza virus is a glycosylated type I integral membrane
protein that protrudes from the mature virion surface and plays critical roles in viral interactions
with hosts. The HA protein is synthesized in infected cells as a precursor HA0, and is subsequently
cleaved by cellular proteases to HA1 and HA2 subunits that are covalently attached by a disulfide
bond. The mature HA protein on the virion is composed of three pairs of the HA1/HA2 subunits
(Ha et al., 2003). The tip of the HA protein forms a globular structure, termed the globular head,
and confers on the virus an ability to attach cells via interactions with the sialic acid-containing
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glycan moiety on the target cell surface (Ha et al., 2003).
Meanwhile, the HA globular head constitutes the major viral
antigenic sites that induce neutralization antibodies in infected
hosts. These functional and antigenic features drive sequence and
structural variations, particularly near the receptor-binding site
in the globular head, according to specific rules (Smith et al.,
2004; Koel et al., 2013). Importantly, the sequence variation
on the globular head causes various phenotypic changes of
viruses, including changes in antigenicity and receptor specificity.
Therefore, it is critical to determine the structural changes in the
HA globular head in order to understand the viral interplay with
the hosts and evolution. Unfortunately, however, it is usually time
consuming to characterize mutation-induced structural changes
by experimental approaches alone.
Computational science is a rapidly growing area that now
successfully complements the experimental and theoretical
sciences in various fields, including life science. For example,
recent advances in molecular dynamics (MD) simulation enable
us to characterize changes in the three-dimensional structures of
the mutated proteins in relatively short timescales compared with
the experimental approaches (Ode et al., 2012; Sato et al., 2013).
The MD simulations have been used to disclose the structural
basis of the adaptation and evolution of the highly mutable
human immunodeficiency virus (HIV). This includes elucidation
of the HIV structural changes associated with the phenotypic
changes in viral neutralization sensitivity and receptor tropism
(Naganawa et al., 2008; Yokoyama et al., 2012, 2016; Kuwata et al.,
2013), viral sensitivity to antiviral protein (Miyamoto et al., 2012),
viral drug sensitivity (Yuan et al., 2013), viral growth in non-
natural host cells (Yokoyama et al., 2016), and viral sensitivities
to antibodies by drug-resistance mutations (Alam et al., 2016;
Hikichi et al., 2016).
In this study, we used the MD simulation to gain new insights
into the roles of mutations in a recent epidemic variant of the
influenza A(H3N2) viruses. The A(H3N2) viruses have emerged
on 1968 in humans of southern Asia and were soon widespread
in the world. Thereafter, the A(H3N2) has been a major cause
of seasonal influenza in humans to date. During the 2014/15
epidemic season of influenza, a new A(H3N2) substrain had
rapidly predominated in humans worldwide (Skowronski et al.,
2016). Notably, the hemagglutination activity of this substrain
somehow could be measured with only a small portion of the viral
population using a conventional hemagglutination assay with
nonhuman erythrocytes (Skowronski et al., 2016). The A(H3N2)
substrain is characterized by alterations of the N-glycosylation
sequons on the globular heads of the HA protein as compared
with other A(H3N2) clades (Skowronski et al., 2016) and is
now referred to as 3C.2a. The oligosaccharides on the HA
protein play key roles in viral antigenicity (Aytay and Schulze,
1991; Abe et al., 2004; Saito et al., 2004; Ping et al., 2008;
Das et al., 2010; Wang et al., 2010; Wanzeck et al., 2011) and
binding specificity/affinity to the cellular receptor (Gunther et al.,
1993; Ohuchi et al., 1997; Gambaryan et al., 1998; Matrosovich
et al., 1999; Tsuchiya et al., 2002; Wang et al., 2009; de Vries
et al., 2010; Liao et al., 2010). However, it remains unclear how
the 3C.2a mutations altered the HA structure and attenuated
the hemagglutination activity with nonhuman erythrocytes. To
address this issue, we here examined the structural effects of
the four mutations in the globular heads using MD simulations.
The obtained results predicted that the mutations could induce
rearrangement of the glycan shield around the receptor-binding
surface of the HA protein, leading to shrinkage of the ligand-
accessible space.
MATERIALS AND METHODS
Genetic Clades Determination
Genetic clades determination of the influenza virus in Japan
has been performed routinely as the part of the work of the
National Epidemiological Surveillance of Infectious Diseases in
Japan1 and the Global Surveillance of Influenza in the WHO
Reference Laboratories2. Information on the specimen collection
and weekly report of HA type is available on the National
Epidemiological Surveillance of Infectious Diseases3. Briefly,
RNAs were extracted from viruses by using QIAamp viral
RNA kit (QIAGEN, Dusseldorf, Germany). The HA genes were
amplified from extracted RNAs by RT-PCRs using gene-specific
primers (the primer sequences are available upon request) and
SuperScript III One-step RT-PCR system with Platinum Taq
(Invitrogen, Carlsbad, CA, USA). Sequencing reactions were
performed with BigDye terminator kit (Applied Biosystems)
and sequences were determined using 3730xl DNA analyzer
(Applied Biosystems, Foster City, CA, USA). The genetic clades
were determined by the generation of phylogenetic trees of
the HA genes. The phylogenetic trees were constructed using
MEGA 6 software (Tamura et al., 2013) with the neighbor-
joining method. The numbers of HA sequences obtained in
the individual periods are 39, 83, 125, 108, 70, and 77 for
the September 2013 – Jan. 2014, February 2014 – August
2014, September 2014 – January 2015, February 2015 – August
2015, September 2015 – January 2016, and February 2016 –
August 2016, respectively. The nucleotide sequences used in this
study are registered at GISAID, a publicly accessible influenza
virus database4. Accession number at GISAID for the HA
sequence used for the molecular modeling in this study is
EPI543763 (A/Switzerland/9715293/2013 strain).
Molecular Modeling of a Glycosylated
HA Trimer in the Ligand-free State
Three-dimensional (3-D) models for glycosylated extracellular
domains of HA trimers of influenza A (H3N2) in the ligand-free
state were constructed by homology modeling with Molecular
Operating Environment (MOE) (Chemical Computing Group
Inc., Montreal, QC, Canada). The crystal structure of the HA
trimer of the influenza A/Victoria/361/2011 (H3N2) virus (PDB
code: 4O5N; resolution: 1.75 Å; amino acid residues 4–325 and
330–502 for HA1 and HA2 peptides, respectively) was used as
1http://www.nih.go.jp/niid/en/influenza-e.html
2http://www.who.int/influenza/en/
3http://www.nih.go.jp/niid/en/influenza-e/2099-idsc/iasr-flu-e/6791-iasr-inf-
e20160925.html
4http://platform.gisaid.org/epi3/frontend
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the modeling template. Obtained models were optimized by
energy minimization using MOE and an Amber10: Extended
Huckel Theory (EHT) force field implemented in MOE, which
combines Amber10 and EHT bonded parameters for the large-
scale energy minimization (Gerber and Muller, 1995; Case et al.,
2005). The high-mannose oligosaccharide Man5GlcNAc2 was
added to potential N-glycosylation sites in HA using Online
Glycoprotein Builder5.
MD Simulation of Glycosylated HA
Trimer Models
Glycosylated HA trimer models in a ligand-free state were
subjected to MD simulation essentially as described for
simulations of HIV-1 gp120 (Yokoyama et al., 2016). MD
simulations were performed by the PMEMD (Particle Mesh
Ewald Molecular Dynamics) module in the AMBER 14 program
package (Case et al., 2014), employing the Amber ff99SB-
ILDN force field, a protein force field with improved side-
chain torsion potentials (Lindorff-Larsen et al., 2010), the
GLYCAM06 force field, a biomolecular force field for glycans
(Kirschner et al., 2008), and the TIP3P water model for
simulations of aqueous solutions (Jorgensen et al., 1983). Bond
lengths involving hydrogen were constrained with SHAKE, a
constraint algorithm to satisfy a Newtonian motion (Ryckaert
et al., 1977), and the time step for all MD simulations was
set to 2 fs. A non-bonded cutoff of 10 Å was used. After
heating calculations for 20 ps until 310 K using the NVT
ensemble for the constant volume, temperature, and numbers
of particles in the system, simulations were executed using
the NPT ensemble for the constant pressure, temperature, and
numbers of particles in the system at 1 atm, at 310 K, and
in 150 mM NaCl for 100 ns. Root mean square deviations
(RMSDs) between the heavy atoms of the two superposed
proteins were used to measure the overall structural differences
between the two proteins (Case et al., 2005). The RMSD
was calculated using the cpptraj module in AmberTools 14, a
trajectory analysis tool (Case et al., 2014). We used “Computer
System for the Prediction of Mutations of Pathogens” at Research
Center for Zoonosis Control, Hokkaido University for the MD
simulations.
Calculation of Root Mean Square
Fluctuation (RMSF)
We calculated RMSFs of individual components of the high
mannose oligosaccharides Man5GlcNAc2 around the receptor
binding site between 50 to 100 ns of MD simulations to quantify
structural dynamics of glycans during the MD simulations. The
average structures during the last 50 ns of MD simulations
were used as reference structures for RMSF calculation. RMSFs
were calculated as previously described (Naganawa et al., 2008;
Yokoyama et al., 2012, 2016; Kuwata et al., 2013) by using the
ptraj module in Amber, a trajectory analysis tool (Case et al.,
2005).
5http://glycam.org/
RESULTS
Temporal Dynamics of Clade Populations
of A(H3N2) Viruses Since September
2013
Over the 2014/15 influenza season, influenza surveillance reports
from reference laboratories warned of a global epidemic of a
new A(H3N2) variant population, termed 3C.2a. In Japan, the
3C.2a was first detected as a relatively minor population over
the season from February to August in 2014, during which four
A(H3N2) clades co-existed (Figure 1, upper panel). However,
the 3C.2a rapidly became dominant at the beginning of the
winter season in 2015, displaced pre-existing clades, and has
continually predominated at the collection sites in Japan ever
since, representing 76 of 77 (98.7%) clades in the season from
February to August in 2016 (Figure 1, lower panel). In parallel,
another A (H3N2) clade, 3C.3a, which co-existed in the same
period as the 3C. 2a over the February to August 2014 season,
became minor after February 2015 (Figure 1). These results are
consistent with the reports on the global epidemic of the 3C.2a
from the WHO Reference Laboratories6, and suggest the selective
advantage of the 3C.2a for human-to-human transmission during
the study period. Notably, hemagglutination activity of the 3C.2a
was significantly attenuated when measured with a conventional
hemagglutination assay (Skowronski et al., 2016). Together, these
data suggest that certain structural changes occurred in the HA
protein to confer selective advantages on the 3C.2a.
Amino Acid Signatures of the 3C.2a HA
Protein
Molecular epidemiological data from above study and the global
surveillance of influenza in the WHO Reference Laboratories
suggest that the A (H3N2) clades, 3C.2a and 3C.3a, were
diversified from 3C.2 and 3C.3, respectively and thereafter the
3C.2a had dominated over the 3C.3a. Therefore, we examined
differences in HA proteins between the clades 3C.2a and 3C.3a.
The HA protein of the 3C.2a population has multiple amino
acid substitutions as compared with the clade 3C.3a (amino
acid numbers 3, 128, 138, 142, 144, 159, 160, 311, 326, and
489). In this study, we focused on the four substitutions
around the receptor-binding surface on the tip of the HA
protein, i.e., Ala128Thr, Asn144Ser, Ser159Tyr, and Lys160Thr
(Figure 2). The Ala128Thr and Lys160Thr create new potential
N-glycosylation sites, Asn-X-Ser/Thr, whereas Asn144Ser results
in the loss of a single N-glycosylation site. Ser159Tyr is located
adjacent to the Lys160Thr. The Ala128Thr substitution initially
detected in the 3C.2 and had been preserved in its descendent,
3C.2a, whereas the other three substitutions newly emerged in
the 3C.2a (Figure 2A). All the mutations are placed at or near
the major antigenic elements for H3 HAs, such as antigen sites A
(amino acids 140-146) and B (amino acids 155-160 and 188-198)
(Webster and Laver, 1980; Gerhard et al., 1981; Wiley et al., 1981;
Knossow et al., 1984; Wiley and Skehel, 1987) (Figure 2B).
6http://www.who.int/influenza/en/
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FIGURE 1 | Temporal dynamics of clade populations of A (H3N2) viruses since September 2013. The clade-populations based on the phylogenetic tree of
the hemagglutinin (HA) genes are shown by pie charts. The periods of each pie chart are determined by the collection dates of specimens. The clades are colored as
follows: 3C.2, light blue; 3C.2a, blue; 3C.3, light orange; 3C.3a, orange; 3C.3b, light magenta.
MD Simulations of Glycosylated HA
Trimers in the Ligand-free State
To understand the structural impacts of the four mutations on the
tip of the 3C.2a HA protein, we constructed molecular models of
the glycosylated HA trimers with and without the mutations. Two
structural models of the glycosylated HA trimers in a ligand-free
state were constructed by homology modeling: a model for the
A(H3N2) 2015/16 vaccine strain (A/Switzerland/9715293/2013)
that belongs to the perishing clade 3C.3a (Figures 1, 2) and
a model for A/Switzerland/9715293/2013 possessing the four
3C.2a-specific mutations on the HA globular heads (Ala128Thr,
Asn144Ser, Ser159Tyr, and Lys160Thr). The obtained models
were optimized by energy minimization using the MOE:EHT
force field (Gerber and Muller, 1995; Case et al., 2005) and were
subjected to the MD simulations using the Amber ff99SB-ILDN
force field (Lindorff-Larsen et al., 2010) and the GLYCAM06 force
field (Kirschner et al., 2008) as described previously (Yokoyama
et al., 2016).
The structural dynamics of the glycosylated HA proteins
in solution were monitored by RMSD between the initial
model structure and the structures at given time points of
the MD simulation (Figure 3). For the protein portions of
the glycosylated HA molecules, the RMSDs sharply increased
in the beginning and reached a near plateau after 20 ns of
the MD simulations in both the 3C.3a and its mutant with
3C.2a mutations (Figures 3A,B). This RMSD profile was similar
to that obtained with the glycosylated HIV-1 gp120 protein
(Yokoyama et al., 2016). In addition, we monitored the RMSDs
of the glycan portions of the glycosylated HA molecules. We
obtained an RMSD profile that was similar to that of the protein
portions: there was a sharp increase soon after the MD simulation
onset followed by a near plateau after 20 ns (Figures 3C,D).
These results suggest that the structural distortions of the amino
acid residues and glycans of the initial models were relieved
shortly after the start of MD simulation under thermodynamic
driving forces in solution. The data also predict that the HA
structure can reach a state of thermodynamic equilibrium in
solution.
Finally, we compared the 3-D structure of the HA trimer in a
state of thermodynamic equilibrium during the MD simulations
(100 ns) between the 3C.3a and its mutant (Figure 4A). A marked
structural difference between the 3C.3a and its mutants was
detected on the globular heads of the HA protein at 100 ns of two
MD simulations: the glycan moieties were placed more compactly
in the mutant than in the 3C.3a (Figures 4A,B). Consequently,
the space for the access of ligands around the receptor-binding
site was more confined in the mutant (Figure 4C). The apical
spaces for ligand binding could be influenced not only by
the arrangements of glycans but also by fluctuation of the
glycans. Therefore, we examined structural fluctuations of the
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FIGURE 2 | Amino acid signatures of the 3C.2a HA protein. Types and
3-D locations of amino acid substitutions around the receptor-binding surface
on the tip of the HA protein are shown. (A) Types of amino acid residues
among five A(H3N2) variant strains emerged in the 2013–2016 periods in
Japan. (B) Locations of different amino acid residues between 3C.3a and
3C.2a are highlighted by cyan color on the HA protein model of the 3C.3a
strain (A(H3N2) 2015/16 vaccine strain: A/Switzerland/9715293/2013).
individual glycans around the receptor binding site by calculating
RMSF using snapshots of structures from 50 to 100 ns of
each MD simulation. In the present HA models, the high
mannose oligosaccharides Man5GlcNAc2 were attached on the
asparagine residues of potential N-glycosylation sites around
the receptor binding site (Figure 5A). We calculated RMSFs of
individual components of the oligosaccharides, such as GlcNAc
and Man, at positions 1 to 7 (Figure 5B). Notably, RMSFs
of the glycan components at given positions, and the profiles
of RMSFs at the seven positions were similar among the four
N-glycosylation sites. The data indicate that all glycans fluctuated
in a similar fashion around the receptor binding site during the
MD simulations. These results suggest that the apical spaces for
ligand binding are mainly influenced by arrangements of glycans
and that the spaces are constantly different between the two
models during the MD simulations.
DISCUSSION
In this report, we studied the structural impact of mutations
residing in the HA globular head of a recent epidemic
clade population of the A(H3N2). This clade, termed 3C.2a,
predominated over other co-existing A(H3N2) clades including
the clade 3C.3a during the 2014/15 and 2015/16 seasons, and
retained a unique set of sequon mutations in the HA globular
heads (Figures 1, 2). To analyze the HA structures under near
physiological conditions, we performed MD simulations of the
glycosylated HA trimers and obtained structures in a state of
thermodynamic equilibrium in solution (Figure 3). Comparisons
of the obtained structures revealed marked changes in the glycan
shield around the receptor-binding site (Figures 4, 5). This
finding has important implications for our understanding of
phenotypic changes, evolution, and fate of the influenza virus
A(H3N2).
First, the present results indicate that the 3C.2a-specific
mutations have an impact on the immunological features of
the HA protein. Our MD simulations show that the glycans
on the HA globular head are rearranged by the mutations into
a configuration markedly distinct from that of the 2015/16
vaccine strain (Figures 4, 5). Therefore, these mutations could
induce changes in the HA antigenicity. These structural findings
are consistent with previous reports demonstrating critical
roles of the oligosaccharides on the HA protein in the viral
antigenicity of influenza viruses (Aytay and Schulze, 1991; Abe
et al., 2004; Saito et al., 2004; Ping et al., 2008; Das et al.,
2010; Wang et al., 2010; Wanzeck et al., 2011). Moreover,
we found that the glycan rearrangement resulted in shrinkage
of the access space on the top of the HA protein near the
receptor-binding site of the globular head (Figure 4). This
structural change could cause steric hindrance for binding
of the antibodies directed to the antigen site B. Thus, it
is likely that the HA protein of the 3C.2a had a selective
advantage in evading antibodies against receptor-binding site
as compared with the 3C.3a HA. These possibilities are
consistent with the rapid spread and predominance of the clade
C3.2a over the clade 3C.3a in human populations during the
study period (Figure 1) (Skowronski et al., 2016). Antigenic
analysis of these viruses should be done to make sure these
possibilities.
Secondly, the present results indicate that the 3C.2a-specific
mutations impact the receptor specificity of the HA protein. Our
MD simulations showed that the new arrangement of glycans on
the HA globular head could shrink the space for the access of
the sialic acid-containing glycan moiety on the target cell surface
(Figure 4). This structural change could cause an increase in the
ligand specificity and/or affinity of the HA protein, and thereby
lead to a preference for receptors on the human respiratory
organs, but not for receptors on the nonhuman erythrocytes.
These structural findings are consistent with the attenuation of
hemagglutination activity of the 3C.2a HA protein when assessed
with a conventional hemagglutination assay using nonhuman
erythrocytes (Skowronski et al., 2016). Similarly, previous studies
have demonstrated that the oligosaccharides on the HA protein
surface play key roles in the binding specificity and the affinity
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FIGURE 3 | Molecular dynamics (MD) simulations of glycosylated HA trimers in a ligand-free state. Molecular models of glycosylated extracellular domains
of HA trimer in a ligand-free state were constructed by homology modeling using MOE (Chemical Computing Group Inc., Montreal, QC, Canada) and subjected to
MD simulations using the AMBER 14 program package (Case et al., 2014) as described in the Section “Materials and Methods”. The structural dynamics of the HA
trimers in solution were monitored by root mean square deviations (RMSD) between the initial model structure and the structures at given time points of MD
simulation. (A,C) HA trimer of a representative strain (A/Switzerland/9715293/2013) belonging to the subclade 3C.3a. (B,D) HA trimer of the
A/Switzerland/9715293/2013 with Ala128Thr, Asn144Ser, Ser159Tyr, and Lys160Thr substitutions. (A,B) RMSDs of the protein portions. (C,D) RMSDs of N-glycans.
to infection receptors (Gunther et al., 1993; Ohuchi et al., 1997;
Gambaryan et al., 1998; Matrosovich et al., 1999; Tsuchiya et al.,
2002; Wang et al., 2009; de Vries et al., 2010; Liao et al., 2010).
Thirdly, the present findings have implications in terms of
the adaptive evolution of A (H3N2). Previous reports have
highlighted the importance of changes in the glycan shield for
viral adaptation (Deom et al., 1986). Interestingly, the numbers
of potential N-glycosylation sites in the HA protein have been
continuously increasing since 1968: only two sequons existed –in
the initial strains, whereas more than 7–10 sequons are common
in the present epidemic strains (Blackburne et al., 2008). This
change is likely to be a basic strategy by which A (H3N2) has
maintained its presence in human populations with changing
herd immunity over the last 48 years. However, the change also
runs the risk of creating an evolutionary “dead-end” for the
virus, because the acquisition of new glycans on the HA globular
head increases the chances for steric hindrance during receptor
binding. Notably, both the present and recent studies suggest that
the HA protein possessing the 3C.2a-type glycan shield would
significantly affect ligand specificity (Figure 4) (Skowronski et al.,
2016). Thus, the 3C.2a has evolved an HA structure that is
advantageous for evading pre-existing antibodies, while also
reducing ligand affinity to nonhuman glycan moieties.
Finally, the present have structural implications in the
fate of influenza A (H3N2) viruses. Our study indicates that
an increase in the number of the glycan moieties around
the receptor-binding site could induce a drastic reduction in
the apical space for ligand binding (Figure 4). As discussed
above, continuous interactions between A (H3N2) and human
immunity seem to force the virus to serially increase the numbers
of glycans on the HA protein. This eventually may reduce the
HA binding affinity via an increase in steric hindrance even
to the human ligands, and thereby decrease the replication
fitness of the virus for spread among humans. Thus, if the
overall tendency of HA to increase the numbers of glycosylation
sites (Blackburne et al., 2008) continues in the future, it may
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FIGURE 4 | Comparison of HA trimer models at 100 ns of MD simulations. The 3-D structure of the HA trimer in a state of thermodynamic equilibrium during
the MD simulations (100 ns) was compared between the vaccine strain and its mutant. (A) Side view, (B) top view. (C) Receptor-binding region. Helix and loops in
the receptor-binding site are marked by red and blue colors, respectively. The tryptophan at position 153 for the binding of sialic acid is shown.
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FIGURE 5 | Molecular dynamics of the individual glycans around the receptor binding site. (A) Illustration of components of the high mannose
oligosaccharides Man5GlcNAc2. (B) Root Mean Square Fluctuation (RMSF) of oligosaccharides. Structural fluctuations of the individual components of glycans
around the receptor binding site of the HA proteins were analyzed by calculating RMSF using snapshots of structures from 50 to 100 ns of each MD simulation. The
average structures during the last 50 ns of MD simulations were used as reference structures for RMSF calculation.
eventually put the influenza A (H3N2) viruses in an evolutionary
cul-de-sac.
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